Protocol Summary

Protocol No.: OCR15562

Sponsor Protocol No.: TARGET-HCC

Study Title
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma

Principal Investigator(s)
Cabrera, Roniel

TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.

Phase: NA

Age Group: Adult

Scope: National

Detailed Eligibility
1. Ages 18 years old and older
2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)

1. Inability to provide written informed consent

Applicable Disease Sites

Liver Cancer

Participating Institutions
UF Gainesville : Patrick Horne

Patrick Horne
Phone: +1 352-273-9464

More Information:
View study listing on